Cell and gene therapies
-
Gilead gets second CAR T deal
- 20 Dec 2023
More than two years after its initial recommendation, Australians are finally close to funded access for the country’s third cell therapy.
Read more -
Gallaher to lead new CGT centre
- 18 Dec 2023
Entrepreneur Michelle Gallaher named inaugural CEO of Cerulea, a new clinical trial centre investigating gene therapies for eye disorders.
Read more -
Aust struggles with high-cost therapies
- 13 Dec 2023
Study of 13 new products across 20 countries found Australia lagged well behind others in reimbursing cell and gene therapies.
Read more -
Vertex scores second CRISPR approval
- 11 Dec 2023
Gets an all-important tick in the US as bluebird bio’s CAR T-cell therapy secures FDA approval for the same blood disease.
Read more -
BioNTech sets up in Melbourne’s La Trobe
- 08 Dec 2023
Planning to develop and commission a state-of-the-art mRNA clinical-scale manufacturing facility at the University’s Melbourne campus.
Read more -
Government responds to New Frontier
- 01 Dec 2023
The long-awaited response to the House of Reps report is here. See which of its 31 recommendations got a green light.
Read more -
Dr Mike clears path for genomic revolution
- 29 Nov 2023
MP calls for laws to restrict access to genetic information ahead of the Government’s tabling of its response to his New Frontier report.
Read more -
First win for genetic testing
- 29 Nov 2023
Jane Tiller and Krystal Barter have notched up their first win in their long battle to end the use of genetic test results in insurance rating.
Read more